Norwegian Securities Trading Act.

All filings by Norwegian Securities Trading Act. on record concern Gentian Diagnostics ASA. The record holds 4 filings, for trades running from 28 February 2022 to 29 August 2022.

No open-market sale appears; the market trades are 4 purchases worth €123k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

A typical purchase (the median) is worth €15k. None of the 4 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The record was last updated on 29 August 2022 with an open-market purchase (€89k) in Gentian Diagnostics ASA. These figures are compiled from regulatory filings published by Oslo Børs. They describe what insiders did and are not a recommendation.